Importantly, the administration of the NOD1 ligand promoted significant changes in all the hallmarks of asthma models including increased AHR and eosinophil recruitment, higher levels of seric specific IgE and IL13 production among other asthma-related mediators (125). The gene discussed is IL13; the disease is asthma.